Abstract:Background: MicroRNAs (miRNAs) play a vital role in the bone development and bone regeneration. In this study, we investigated the effects of miR-26a in osteoblasts and fractures.Methods: Human osteoblasts were cultured and used for analysis. To identify differential miRNAs in blood samples from patients with fractures and healthy controls, quantitative real-time polymerase chain reaction (qRT-PCR) analysis was performed. Human osteoblasts were transfected with miR-26a mimics, miR-26a inhibitor, or their corresponding negative controls (NCs), respectively. MTT assay was performed to identify the effects of miR-26a on the cell viability of osteoblasts. EdU staining was applied to detect the proliferation of osteoblasts. Trypan blue staining was utilized to analyze the effects of miR-26a on the cell death of osteoblasts. Terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) staining was used to detect apoptotic osteoblasts. Alizarin red S (ARS) staining and qRT-PCR analysis were utilized to measure the mineralized nodule formation to evaluate the bone formation of osteoblasts. Dual luciferase reporter assay and western blot analysis were performed to detect the relationship between miR-26a and its target gene.Results: The results of qRT-PCR analysis identified miR-26a as our miRNA of interest and indicated that miR-26a was significantly decreased in patients with fractures. Overexpression of miR-26a significantly increased the cell viability and proliferation of osteoblasts. An increase in miR-26a reduced the cell death and apoptosis of osteoblasts, and promoted the osteoblastic activity and mineralized nodule formation. Dual luciferase reporter assay, qRT-PCR and western blot analysis showed that miR-26a could negatively regulate the expression of phosphatase and tensin homolog (<i>PTEN</i>).Conclusions: MiR-26a promoted new bone regeneration via regulating the functions of osteoblasts by targeting its target gene <i>PTEN</i>. Therefore, we propose that targeting miR-26a may be a novel therapeutic method for bone regeneration and treating fractures.

The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a

MicroRNA-378 Promotes Osteogenesis-Angiogenesis Coupling in BMMSCs for Potential Bone Regeneration

Lentivirus‑mediated microRNA‑26a overexpression in bone mesenchymal stem cells facilitates bone regeneration in bone defects of calvaria in mice

The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair

Integrated Osteoinductive Factors─Exosome@MicroRNA-26a Hydrogel Enhances Bone Regeneration

MicroRNAs Involved in the Regulation of Angiogenesis in Bone Regeneration

The regulatory roles of miR-26a in the development of fracture and osteoblasts

DP7‐C/mir‐26a system promotes bone regeneration by remodeling the osteogenic immune microenvironment

Development of miR-26a-activated scaffold to promote healing of critical-sized bone defects through angiogenic and osteogenic mechanisms

miRNA-21 promotes osteogenesis via the PTEN/PI3K/Akt/HIF-1α pathway and enhances bone regeneration in critical size defects

The Role of Antimir-26A-5p/biphasic Calcium Phosphate in Repairing Rat Femoral Defects.

MiRNAs regulate cell communication in osteogenesis-angiogenesis coupling during bone regeneration

MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice

MiR-26b-5p/TET3 regulates the osteogenic differentiation of human bone mesenchymal stem cells and bone reconstruction in female rats with calvarial defects

The promotion of bone regeneration through CS/GP-CTH/antagomir-133a/b sustained release system

Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects

Bone marrow mesenchymal stem cell-derived exosomes loaded with miR-26a through the novel immunomodulatory peptide DP7-C can promote osteogenesis

Author Response for "dp7‐c/mir‐26a System Promotes Bone Regeneration by Remodeling the Osteogenic Immune Microenvironment"

A Tetrahedral DNA Nanostructure-Mediated Mirna Inhibitor Delivery System: Type H Vessel-Related Bone Healing During Distraction Osteogenesis

MicroRNA-495 Inhibits New Bone Regeneration Via Targeting High Mobility Group AT-Hook 2 (HMGA2)

Delivery of Therapeutic Mirnas Using Nanoscale Zeolitic Imidazolate Framework for Accelerating Vascularized Bone Regeneration